Close Menu
    Irani KhabarIrani Khabar
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Irani KhabarIrani Khabar
    Home » As COVID-19 cases soar again in China, cremations are rising
    Health

    As COVID-19 cases soar again in China, cremations are rising

    December 22, 2022
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    The Chinese government has already prepared for an inevitable spike in deaths related to COVID-19 following the reversal of Beijing’s “zero-COVID” policy. In response to widespread protests, the government loosened its restrictions, which many in the country believe contributed to the death of ten people in a fire that occurred in a high-rise apartment building.

    As COVID-19 cases soar again in China, cremations are risingAs cases soared, China’s health care system was caught unprepared and scrambling to find beds and medicines to maintain clinics. There have been tens of thousands of fever clinics added to hospitals and even sports arenas in major cities throughout China, including Beijing, Shanghai, Chengdu, and Wenzhou. Asymptomatic cases are no longer reported by officials.

    Experts have already predicted that China could experience more than one million COVID-related deaths next year. According to Our World in Data, a spike occurred in March of this year with a rolling average of 26,570. The current wave peaked at 40,791 cases with a high of 62,439 on Dec. 2. Prior to the rollback of zero-COVID, WHO Emergencies Director Mike Ryan argued that “the control measures in themselves were not stopping the disease.”

    There is a significant lack of vaccinations in China, which contributes to the difficulty. As of December, China was delivering 100,000 to 200,000 doses per day. As of Dec. 13, that number had risen to more than 1.43 million. For years, China refused to adopt vaccines from the West. Instead, it relied on a vaccine called Sinopharm that doesn’t use mRNA models. These introduce antigen templates without exposing people to real viruses. Compared to older vaccine models, the more recent vaccines also scale and produce faster.

    China has approved the Pfizer-BioNTech vaccine for use, with the first batch being sent out Wednesday. There were no details on the size or timing of the delivery. Currently, the vaccine is only available to Germans living in China, but Beijing plans to use it for Chinese nationals as well. The country has around 20,000 Germans. As an exchange, Chinese citizens in Germany can receive SinoVac.

    Related Posts

    Congo Ebola cases rise as outbreak widens

    June 19, 2026

    Ebola cases in DR Congo rise as WHO warns on spread

    June 13, 2026

    DR Congo Ebola cases rise to 598 as deaths reach 115

    June 10, 2026

    WHO reports 507 Ebola cases across Congo and Uganda

    June 8, 2026

    Global health bodies seek $518 million for Ebola response

    June 6, 2026

    WHO says Congo Ebola response improves as challenges remain

    June 4, 2026
    Latest News

    Portugal beats 50th-ranked Uzbekistan in World Cup Group K

    June 24, 2026

    China and EU trade chiefs set for Brussels talks

    June 24, 2026

    Norway reach World Cup knockouts with 3-2 Senegal win

    June 24, 2026

    Argentina advance as Messi breaks World Cup scoring record

    June 23, 2026

    Japan’s Nikkei 225 clears 72,000 in record Tokyo rally

    June 22, 2026

    Egypt claims historic World Cup win over New Zealand

    June 22, 2026

    Japan widens AI risk cooperation in updated safety plan

    June 22, 2026

    US beats Australia to reach World Cup Round of 32

    June 20, 2026
    © 2026 Irani Khabar | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.